Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial.
Abstract
5023
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 20, 2020
- Source ID
- 10.1200/jco.2020.38.15_suppl.5023
Entities
People
- Arlene Sharpe
- Catherine J Wu
- David A Braun
- David F McDermott
- Eliezer Mendel Van Allen
- F Stephen Hodi
- Gordon J. Freeman
- Jean-christophe Pignon
- Maxine Sun
- Megan Wind-Rotolo
- Michael B Atkins
- Miriam Ficial
- Miriam Sant’angelo
- Opeyemi Jegede
- Paul J. Catalano
- Robert J. Motzer
- Sabina Signoretti
- Sachet A Shukla
- Sonia Moreno
- Toni K Choueiri
Organizations
- Beth Israel Deaconess Medical Center
- Brigham and Women's Hospital
- Bristol-Myers Squibb
- Dana–Farber Cancer Institute
- Georgetown Lombardi Comprehensive Cancer Center
- Harvard Medical School
- Memorial Sloan Kettering Cancer Center
- National Institutes of Health
- United States Department of Defense